URI-sponsored BEACON study seeks blood vessel inflammation, Alzheimer’s link

THE GEORGE & ANNE Ryan Institute for Neuroscience researchers will investigate reduction of brain blood vessel inflammation in fighting Alzheimer’s disease as part of the $1.3 million, University of Rhode Island-sponsored, BEACON study. Above, Paula Grammas, executive director of the Ryan Institute. / COURTESY NORA LEWIS
THE GEORGE & ANNE Ryan Institute for Neuroscience researchers will investigate reduction of brain blood vessel inflammation in fighting Alzheimer’s disease as part of the $1.3 million, University of Rhode Island-sponsored, BEACON study. Above, Paula Grammas, executive director of the Ryan Institute. / COURTESY NORA LEWIS
SOUTH KINGSTOWN — George & Anne Ryan Institute for Neuroscience researchers will investigate reduction of brain blood vessel inflammation in fighting Alzheimer’s disease as part of the $1.3 million, University of Rhode Island-sponsored, BEACON study, the first such clinical trial led and conducted entirely within the state. The Phase 1 clinical trial, mainly funded by…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -